| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/1348-0421.12333 |
| P698 | PubMed publication ID | 26500022 |
| P2093 | author name string | Jung-Joon Min | |
| Yeongjin Hong | |||
| Hyon E Choy | |||
| Thuy Xuan Phan | |||
| Vu Hong Nguyen | |||
| Mai Thi-Quynh Duong | |||
| P2860 | cites work | The inflammasomes | Q24304087 |
| Cryopyrin activates the inflammasome in response to toxins and ATP | Q28291313 | ||
| Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages | Q28594887 | ||
| Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration | Q29615596 | ||
| The inflammasome NLRs in immunity, inflammation, and associated diseases | Q29616025 | ||
| Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis | Q29619852 | ||
| New paradigm for tumor theranostic methodology using bacteria-based microrobot | Q30558192 | ||
| Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha | Q33495169 | ||
| IL-1beta processing in host defense: beyond the inflammasomes | Q33535878 | ||
| Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
| Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome | Q33733606 | ||
| Extracellular ATP in the immune system: more than just a "danger signal". | Q34015956 | ||
| ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages | Q34328636 | ||
| Mechanisms of the antitumoral effect of lipid A. | Q34561527 | ||
| A novel balanced-lethal host-vector system based on glmS. | Q34654013 | ||
| NLRP3 inflammasomes link inflammation and metabolic disease | Q35151726 | ||
| Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | Q36191597 | ||
| Sensing and reacting to microbes through the inflammasomes | Q36253171 | ||
| The P2X7 receptor: a key player in IL-1 processing and release | Q36425273 | ||
| Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation | Q36691082 | ||
| Liaisons dangereuses: P2X(7) and the inflammasome. | Q36907699 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
| Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity | Q37677942 | ||
| Phenotypic differences between Salmonella and Escherichia coli resulting from the disparate regulation of homologous genes | Q37693828 | ||
| The NLRP3 inflammasome, a target for therapy in diverse disease states | Q37702149 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin | Q39632623 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Injection of flagellin into the host cell cytosol by Salmonella enterica serotype Typhimurium | Q40073247 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| P433 | issue | 11 | |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| inflammasome complex | Q412405 | ||
| P304 | page(s) | 664-675 | |
| P577 | publication date | 2015-10-24 | |
| P1433 | published in | Microbiology and Immunology | Q15767399 |
| P1476 | title | Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy | |
| P478 | volume | 59 |
| Q38850160 | Antimelanoma effect of Salmonella Typhimurium integration host factor mutant in murine model |
| Q64946431 | Bacteria in Cancer Therapeutics: A Framework for Effective Therapeutic Bacterial Screening and Identification. |
| Q91890842 | Bacteria-cancer interactions: bacteria-based cancer therapy |
| Q50333648 | Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions |
| Q57300412 | Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated |
| Q50317370 | Cell mass-dependent expression of an anticancer protein drug by tumor-targeted Salmonella |
| Q92135546 | Deoxynivalenol enhances IL-1ß expression in BV2 microglial cells through activation of the NF-?B pathway and the ASC/NLRP3 inflammasome |
| Q54213329 | Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models. |
| Q47126937 | Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy |
| Q37699536 | Inflammasomes in Inflammation-Induced Cancer |
| Q37112974 | RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy |
| Q91743156 | Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy |
| Q90618645 | Salmonella-Mediated Cancer Therapy: An Innovative Therapeutic Strategy |
| Q28069354 | Targeted Cancer Therapy Using Engineered Salmonella typhimurium |
| Q53699248 | The role of bacteria in cancer therapy - enemies in the past, but allies at present. |
| Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
| Q47587450 | Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin |
Search more.